[
1. Li Y,Ma Y,Wu Z, et al. Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma. Front Immunol. 2021;12:790674.Published 2021 Nov 25. doi:10.3389/fimmu.2021.790674.10.3389/fimmu.2021.790674865643234899760
]Search in Google Scholar
[
2. Shukla G,Alexander GS,Bakas S,Nikam R,Talekar K,Palmer JD,Shi W. Advanced magnetic resonance imaging in glioblastoma: a review. Chin Clin Oncol. 2017 Aug;6(4):40. doi: 10.21037/cco.2017.06.28. PMID:28841802.10.21037/cco.2017.06.2828841802
]Search in Google Scholar
[
3. Gonçalves FG,Chawla S,Mohan S. Emerging MRI Techniques to Redefine Treatment Response in Patients With Glioblastoma.J Magn Reson Imaging.2020 Oct;52(4):978-997. doi: 10.1002/jmri.27105.Epub 2020 Mar 19.PMID: 32190946;PMCID: PMC7492394.10.1002/jmri.27105
]Search in Google Scholar
[
4. Dützmann S,Geßler F,Bink A,Quick J,Franz K,Seifert V,Senft C. Risk of ischemia in glioma surgery: comparison of first and repeat procedures. J Neurooncol. 2012 May;107(3):599-607. doi:10.1007/s11060-011-0784-1. Epub 2012 Jan 17. PMID: 22249690.10.1007/s11060-011-0784-122249690
]Search in Google Scholar
[
5. Chen CW,Cheng TJ,Ho CH,Wang JJ,Weng SF,Hou YC,Cheng HC,Chio CC,Shan YS,Chang WT. Increased risk of brain cancer incidence in stroke patients: a clinical case series, population-based and longitudinal follow-up study.Oncotarget.2017 Nov 15;8(65):108989-108999. doi: 10.18632/oncotarget.22480.PMID: 29312585;PMCID:PMC5752498.10.18632/oncotarget.22480
]Search in Google Scholar
[
6. Gaudino S,Martucci M,Russo R,Visconti E,Gangemi E,D’Argento F,Verdolotti T,Lauriola L, Colosimo C. MR imaging of brain pilocytic astrocytoma:beyond the stereotype of benign astrocytoma. Childs Nerv Syst. 2017 Jan;33(1):35-54. doi:10.1007/s00381-016-3262-4.Epub 2016 Oct 18.PMID:27757570.10.1007/s00381-016-3262-4
]Search in Google Scholar
[
7. Kee HJ,Ahn KY,Choi KC,Won Song J,Heo T,Jung S,Kim JK,Bae CS,Kim KK. Expression of brain-specific angiogenesis inhibitor 3 (BAI3) in normal brain and implications for BAI3 in ischemia-induced brain angiogenesis and malignant glioma. FEBS Lett.2004 Jul 2;569(1-3):307-16. doi: 10.1016/j.febslet.2004.06.011.PMID:15225653.10.1016/j.febslet.2004.06.011
]Search in Google Scholar
[
8. Ohgaki H,Kleihues P. The definition of primary and secondary glioblastoma. Clin Cancer Res. 2013 Feb 15;19(4):764-72. doi:10.1158/1078-0432.CCR-12-3002.Epub 2012 Dec 3.PMID: 23209033.10.1158/1078-0432.CCR-12-3002
]Search in Google Scholar
[
9. Chawla S,Shehu V,Gupta PK,Nath K,Poptani H. Physiological Imaging Methods for Evaluating Response to Immunotherapies in Glioblastomas. Int J Mol Sci.2021 Apr 8;22(8):3867. doi: 10.3390/ijms22083867.PMID: 33918043;PMCID:PMC8069140.10.3390/ijms22083867
]Search in Google Scholar
[
10. Berghoff AS,Hainfellner JA,Marosi C,Preusser M. Assessing MGMT methylation status and its current impact on treatment in glioblastoma. CNS Oncol.2015;4(1):47-52. doi: 10.2217/cns.14.50.PMID: 25586425;PMCID:PMC6093023.10.2217/cns.14.50
]Search in Google Scholar
[
11. Wojtasiewicz, Teresa J et al. “De novo glioblastoma in the territory of a prior middle cerebral artery infarct.”Case reports in neurological medicine vol.2013 (2013):356526. doi:10.1155/2013/356526.10.1155/2013/356526381031924222871
]Search in Google Scholar
[
12. Colman H. Adult Gliomas.Continuum(Minneap Minn).2020 Dec;26(6):1452-1475. doi: 10.1212/CON.0000000000000935.PMID: 33273168.10.1212/CON.0000000000000935
]Search in Google Scholar
[
13. Haque A,Banik NL,Ray SK. Molecular alterations in glioblastoma:potential targets for immunotherapy.Prog Mol Biol Transl Sci.2011;98:187-234. doi:10.1016/B978-0-12-385506-0.00005-3.PMID: 21199773;PMCID: PMC4287208.10.1016/B978-0-12-385506-0.00005-3
]Search in Google Scholar
[
14. Teresa J.Wojtasiewicz,Andrew F.Ducruet,”De Novo Glioblastoma in the Territory of a Prior Middle Cerebral Artery Infarct”,Case Reports in Neurological Medicine, vol. 2013,Article ID 356526,5 pages,2013. https://doi.org/10.1155/2013/35652610.1155/2013/356526
]Search in Google Scholar
[
15. Odjélé A,Charest D,Morin P Jr. miRNAs as important drivers of glioblastomas: a no-brainer? Cancer Biomark. 2012;11(6):245-52. doi:10.3233/CBM-2012-0271. PMID: 23248182.10.3233/CBM-2012-027123248182
]Search in Google Scholar
